Shareholders have approved a massive transaction that could create a conglomerate in the marijuana industry.

On Wednesday (June 19), investors of New York-based multi-state operator (MSO) Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF) and Canadian producer Canopy Growth (NYSE:CGC,TSX:WEED) okayed a deal between the two firms.

Canopy Growth spent US$300 million to get the option to acquire Acreage when marijuana becomes federally legal in the US. In total, the transaction is estimated to be worth US$3.4 billion.

Shareholders from both firms overwhelmingly voted in support of the deal, with 95 percent of Acreage investors and 99.05 percent of Canopy Growth holders agreeing to the outlined terms of the acquisition.

“Alongside our international market strategies and US Hemp strategy, we believe the acquisition of Acreage will be a key step in bolstering our position as a truly global company,” Bruce Linton, co-CEO of Canopy Growth, said in a press release.

Kevin Murphy, founder and CEO of Acreage, thanked shareholders for approving the deal.

Shares of the two companies enjoyed a slight jump in Wednesday’s trading session.

Shares of Canopy Growth in New York and Toronto finished the day respectively at US$42.77 and C$56.85, representing price increases of 1.74 percent and 0.87 percent, while shares of Acreage increased by 3.16 percent for a closing price of US$19.60.

Now, with voter support, shareholders will wait to see just how long it will be until Canopy Growth can complete its acquisition.

Acreage management has indicated that it will race to expand its portfolio so that once Canopy Growth can swoop in and complete the transaction, the Canadian firm will obtain a larger MSO.

After the original announcement of the deal, Alan Brochstein, cannabis analyst with 420 Investor, highlighted that the MSO will now be capable of hitting the market and finding quality partners to expand its own business.

As part of the deal, Acreage will also gain use of the brands and intellectual property held by Canopy Growth.

“We expect that potential acquisition candidates will have more confidence in the equity of Acreage given that it will be tethered to Canopy,” he said.

Steve West, vice president of investor relations at Acreage, previously told the Investing News Network that that is the plan for the MSO now: to go out and continue merger and acquisition activity.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Editorial Disclosure: Acreage Holdings is a client of the Investing News Network. This article is not paid-for content.

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 Matica Enterprises Inc. (CSE: MMJ) (OTCQB: MMJFF) (FSE: 39N) (“Matica” or the “Company”) reports the Company has granted 6,500,000 stock options exercisable at $0.05 for five years from date of grant. These include 4,000,000 options to two officers (who are also directors) and, 2,500,000 to two consultants.

For more information on Matica Enterprises please visit the website at:

Keep reading... Show less

The Company welcomes adult-use customers at its eight dispensaries across the state and will create 120 new jobs in surrounding communities

– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced it will begin serving adult-use consumers across its eight dispensaries in Arizona .

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the launch of recreational cannabis sales in Arizona .

Keep reading... Show less

Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.

Keep reading... Show less